{
  "docId": "019de518-7111-73cc-96de-73bae54703a9",
  "docSlug": "f4962453f4d9fd5423495cad460052a8",
  "documentTitle": "Waldencast | Results Presentation Deck | 60 slides",
  "authorId": "waldencast",
  "authorName": "Waldencast",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 32,
  "pageCount": 60,
  "prevPage": 31,
  "nextPage": 33,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 6,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de518-7111-73cc-96de-73bae54703a9/32",
  "deckHref": "/decks/019de518-7111-73cc-96de-73bae54703a9",
  "deckJsonHref": "/decks/019de518-7111-73cc-96de-73bae54703a9.json",
  "deckAnchorHref": "/decks/019de518-7111-73cc-96de-73bae54703a9#slide-32",
  "components": [
    {
      "bbox": {
        "h": 0.07,
        "w": 0.1,
        "x": 0.86,
        "y": 0.05
      },
      "kind": "image",
      "text": "OBAGI MEDICAL",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d124fa1-e6f9-40e4-bc01-cab41ef25cc3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.23,
        "x": 0.73,
        "y": 0.39
      },
      "kind": "metric",
      "text": "ADJ. EBITDA⁴ $20.8M 17.7%⁵",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "163159ac-a6c9-47d8-87fd-3e49f3ad4bd9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.32,
        "x": 0.03,
        "y": 0.39
      },
      "kind": "metric",
      "text": "COMPARABLE NET REVENUE¹ $112.0M +0.2%",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b24c57b4-c267-47bd-b62d-979adb6d6a70",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.29,
        "x": 0.37,
        "y": 0.39
      },
      "kind": "metric",
      "text": "ADJ. GROSS PROFIT² $83.7M 71.2%³",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f882f434-80b1-4c14-bf0b-b4ef2341e094",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.97,
        "x": 0.01,
        "y": 0.87
      },
      "kind": "source-note",
      "text": "1. Comparable Net Revenue excludes $5.6M sales related to the Obagi China Business as well as related party sales under the transition agreement entered into between Waldencast and Obagi China in connection with the Business Combination. The distribution of Obagi Skincare's products in China has remained under the ownership of Cedarwalk Skincare Limited, Obagi Skincare's former owners, who have entered into a licensing and distribution agreement with Waldencast. FY 2023 US GAAP Net Revenue of $117.7M. 2. Gross Profit of $76.6M adjusted for reconciling items, please refer to the Appendix page 51. 3. Adjusted Gross Margin is defined as Adjusted Gross Profit divided by US GAAP Net Revenue. 4. Net Loss of $32.2M adjusted for non-recurring add-backs, please refer to the Appendix page 50. 5. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by US GAAP Net Revenue.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fa4b0925-f129-46a2-b724-ac23d668b843",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.47,
        "x": 0.02,
        "y": 0.07
      },
      "kind": "title",
      "text": "KEY FIGURES FY 2023",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "984388a0-7cfc-47de-93c7-ed4a762257e7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 60,
      "from": 32,
      "beatId": "e5a5d257-6860-45d3-98a7-601644bb0397",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Financial Performance",
      "beatSlug": null,
      "evidence": "The deck presents detailed financial data and key metrics.",
      "position": 5,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 40,
      "from": 32,
      "name": "Maturity Curve",
      "slug": "36-maturity-curve",
      "bestFor": "Digital transformation, capability building, benchmarking",
      "matchId": "34dcf35a-cc41-4328-af2e-dbf7572faf3e",
      "evidence": "The deck presents financial data and key metrics demonstrating the company's growth and maturity.",
      "position": 2,
      "objective": "How will Waldencast continue to grow and mature?",
      "structure": "Current Maturity Level -> The Gap to Next Level -> Required Capabilities -> The Roadmap",
      "confidence": 0.6,
      "description": "Show where you are on a progression and what it takes to reach the next level"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}